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Histocompatibility antigens provoke the rejection of allografts. They induce 
both  humoral  and  cellular  sensitivity.  H-2  antigens  are  the  major  histocom- 
patibility antigens in mice and are analogous to the H-LA  antigens in humans. 
It-2  antigens  are  present  on  cell  membranes.  Both  spleen  cell  membranes 
(SM) 1 and liver cell membranes (LM) from mice absorb alloantibody produced 
specifically against the H-2 antigens  of that strain of mice. However, SM and 
LM behave  differently in vivo. Whereas  SM  causes  accelerated  skin-graft re- 
jection and induces humoral antibody formation against its H-2 antigens,  LM 
has no effect on skin-graft rejection and induces humoral tolerance for its H-2 
antigens  (1).  There is  evidence that  SM contains seroantigens not present  on 
LM (2). Thus, there are important differences between 11-2 antigens on cells of 
the two organs. 
The following experiments  explore  these  differences.  The  experiments  show 
that mixing allogeneic SM with  a  syngeneic liver extract results in a  prepara- 
tion which absorbs  antibody,  which does not immunize for humoral  antibody 
production  or for accelerated  skin-graft rejection,  and  which  tolerizes for hu- 
moral  antibody  production;  i.e.,  major  properties  of  the  allogeneic  SM  are 
transformed into those of allogeneic LM. 
Materials and Methods 
Mouse Strains.--The  mouse strains  used  in  these  experiments were C57BL10Sn  (H-2b), 
C57BL10D2New/Sn  (H-2a), C57BL10Br (II-2~), and C57B10A (H-2  a) provided by Jackson 
Laboratories, Bar Harbor, Me. These will be called B, D, K, and A, respectively. These strains 
are congenic with one another and thus presumably differ only at the H-2 region of the mouse 
genome. 
Melnbrane Preparation.--Membranes were prepared  from spleen and liver by hypotonic 
salt extraction and differential centrifugation  (3). Briefly, mice are killed by cervical disloca- 
tion and their organs immediately removed. The organs are then homogenized in 0.13 M NaC1 
(liver with a Teflon pestle and spleen with a glass grinder) and iced for 30 rain. The homoge- 
* Supported  by grants AM-01006-05 and  AM-05425-11 from the National  Institutes  of 
Health. 
1  Abbreviations used in  this paper: LM,  liver  cell membrane;  MEM,  minimal  essential 
medium; PBS, phosphate-buffered saline; SM, spleen cell membrane. 
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hates are then spun at 2,000 rpm for 20 rain; the supernatants are decanted and saved. The 
pellets are resuspended in 0.11 M NaC1, iced for 30 rain, and spun again. The two supernatants 
are then pooled and spun at 100,000 g for 1 h. The resultant pellets are lyophilized as the final 
"membrane" products. By electron microscopy, these preparations contain pieces of mem- 
branes and endoplasmic reticulum with many microsomes but no nuclei and very few mito- 
chondria. 
Preparation of Liver-Spleen Mixture.--Fig. 1 depicts the method of preparation of the liver- 
spleen mixture used in these experiments. Fresh livers from B mice were homogenized and a 
pooled low-speed crude supernatant prepared exactly as in the methods for membrane prepa- 
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ration. This crude fiver supernatant was then mixed with previously prepared SM from D mice 
at a ratio of supernatant from two livers for each 10 mg SM. The mixture was incubated at 
37°C for 1 h and then spun at 100,000 g for 1 h. The resulting pellet was lyophilized as the final 
liver-spleen mixture, hereafter called mixture. Control preparations were made from identical 
amounts of liver incubated without SM, and S?¢[ incubated without liver. Because all liver and 
all recipient mice used in these experiments were B  type, the liver was nonantigenic in this 
system; i.e., the only H-Z antigens in the mixture recognizable  by B recipients  were those from 
the SM of D mice. 
Skin Grafts.--Split thickness skin grafts 1 cm square were placed on the thorax of the re- 
cipient mouse and bandaged for 6 days. The grafts were scored grossly from the 6th day with 
50% scab taken as the endpoint. Gross scoring for rejection is not as precise as microscopic 
scoring. However in these experimens the graft was needed for antigenic stimulation and could 
not be removed for sectioning. The process of scabbing was progressive and continued to com- 
plete scab formation. Previous comparisons of this scoring method with microscopic scoring S.  NIMELSTEIN,  A.  HOTTI~ AND  H.  HOLMAN  725 
have shown the 50% scab endpoint to be consistent and reliable in distinguishing between 
first and second set responses. 
Injections.--A|l  injections were  intraperitoneal.  Lyophilized antigen  (either the  control 
preparation or  the mixture) was suspended by homogenization in a  volume of phosphate- 
buffered normal saline, pH 6.5 (PBS) so as to make the final volume of injection 0.2 ml per 
mouse. The precise amount of each antigen injected in lyophilized form and its equivalence in 
wet weight of tissue are given in the footnotes to the text. For injection of spleen cells, one fresh 
spleen was glass-ground in 3 ml PBS and 0.1 ml of the suspension injected per mouse. 
Hemagglutination Antibody Assay (ttab Assay).--The  titer of hemagghitinins in a  serum 
was determined by the method of Herzenberg (4). The logl0 of the highest dilution of serum 
giving a 2+ reaction (04+  range) was taken as the "log titer" of a serum; the average of the 
"log titers" was calculated for each group and called the mean log fiter. 
Cytotoxic Antibody  Assay  (Cab Assay).~Cytotoxic  antibody was  assayed  by  measuring 
complement-dependent  51Cr release from lymphocytes exposed  to  appropriate dilutions of 
serum (5). With the percent of 51Cr release in distilled water set as 100% cytotoxicity, the dilu- 
tion of antiserum which would produce 50% cytotoxicity was determined by interpolating or 
extrapolating from the dilutions tested. The logl0 of this titer was taken as the log titer of the 
serum. The mean log titer for each experimental group was calculated. 
Antisera.--Reference B anti-/) sera were prepared by injecting 1/~0 of a B spleen into D mice 
weekly for 6-12 wk. Other antisera came from various experimental groups as indicated in the 
text. 
Absorptions.--To  test lyophilized membrane preparations for absorbing activity, antisera 
were diluted 1 : 10 (in PBS for the Hab assay, in Earle's minimal essential medium [MEM] for 
the Cab assay) and 0.4 ml of this dilution was mixed with an aliquot of antigen in a homogeniz- 
ing tube. The suspension was incubated for 30 rain at 37°C and then spun for 10 min at full 
speed in an Adams serofuge (Clay-Adams, Inc., New York). The supernatant was removed and 
diluted appropriately for the assay. 
Inhibitions.--As a more quantitative measure of antigenicity, a volume of various concen- 
trations of antigen suspension was added to an equal volume of antiserum which had been di- 
luted so as to give approximately 60-80% cytotoxicity in the Cab assay. The decrease in cyto- 
toxicity in the presence of antigen was taken as a measurement of the antigenicity of the prepa- 
ration. 
Statistical Analysis.--Stafistical  significance between groups was determined by the Whit- 
ney-Mann U-Test. Data include standard error of the mean. 
RESULTS 
Initially,  to  test  the antigenicity  of  the liver-spleen  mixture,  we  performed 
simple absorptions of B  anti-D serum. Preparations used for absorption were 1.4 
mg  D  SM,  27.4  mg  mixture,and  27.8  mg  B  liver.  2 Hemagglutination  results 
using D  cells are shown in Table I. Both the D  SM and the mixture  completely 
absorbed the hemagglutinating antibody. By contrast, a  comparable amount  of 
the nonantigenic B  liver did not. In the latter absorption, as occurred about half 
the time, the residual titer was reduced.  In view of the nonantigenic character 
of the absorbing material, the change presumably  represents a  nonspecific inter- 
27.4 mg of mixture was the lyophilized yield from incubating 2.0 mg of lyophilized D SM 
with approximately 400 mg wet weight of B liver. 2.0 mg of D  SM is the yield from approxi- 
mately 100 mg of fresh spleen or one average spleen. 1.4 mg D  SM and 27.8 mg B liver were 
the lyophilized yields from incubating separately 2.0 mg D SM or 400 mg wet weight of B liver. 
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ference with hemagglutination by the foreign material. As shown in Fig. 2, simi- 
lar results were obtained with the cytotoxic assay using D  lymphocytes. Again, 
both the D  SM and the mixture fully absorbed the antiserum, while comparable 
amounts of B  liver did not. Thus, as tested by absorption in either the hemag- 
glutination  or  the  cytotoxic  assay,  the  mixture  possessed  antigenic  activity 
similar to that of SM. On the other hand, the B  liver being nonantigenic in this 
system did not. Different preparations of mixture always gave the same resull. 
As a more quantitative measure of antigenicity, the same preparations were 
used in an inhibition assay. Results are shown in Fig. 3.  Serial dilutions of the 
antigen preparations were added to aliquots of the antiserum, and the test con- 
ducted as described under Methods. As before, B  liver showed no antigenic ac- 
tivity, while D  SM and the mixture showed significant activity. However, be- 
cause a  more dilute suspension of SM inhibited to the same degree as a  more 
TABLE  I 
Hemagglutinating  Activityof B  Anti-D Serum  before and  after Absorption  by  Test Antigens 
Absorbing antigen 
Reciprocal of Dilution of Serum 
I0  20  40  80  160  320  640  1,280 
None  3  4  4  4  3  2  1 
D SM  ....... 
B liver  4  4  4  2  l  1  --  -- 
D SM-B liver  ........ 
Mixture 
concentrated suspension of the mixture, the unreacted SM was more antigenic 
than  a  comparable amount in the mixture (i.e., an amount of mixture derived 
from the starting amount of SM). In fact, from Fig. 3 it can be determined that 
approximately a  ~/~3 dilution of SM  suspension would  have  inhibited  to  the 
point of 50%  cytotoxicity, while approximately a  }~  dilution of mixture sus- 
pension would be needed for the same degree of inhibition. Hence, in this case 
SM was about twice as antigenic as the mixture. 
Next,  we  tested  the ability of the preparations to  sensitize for  accelerated 
skin-graft rejection. Recipient B  mice received a  single injection of antigen 4 
days before receiving a D  skin graft. Amounts used for each injection were 2 mg 
D  SM, 40 mg B  liver, and 40 mg of mixture2 Table II shows the results. Grafts 
on untreated animals and on those animals receiving nonantigenic liver had the 
normal first set median survival  time of l0 days. Mice  receiving SM  rejected 
their grafts in  an  accelerated fashion, i.e.,  7  days.  Finally, grafts on mice in- 
jected with the mixture were rejected in  10  days, a  normal first set rejection. 
a These amounts were the lyophilized  yields  from incubating separately 3 mg D SM, 600 mg 
wet weight B liver, or a mixture of 3 mg D SM with 600 mg B liver. Slightly more material was 
used in these experiments than in the absorptions because we wished a final injection of D SM 
to equal the yield from approximately 100 mg wet weight of spleen. This amount of allogeneic 
spleen provokes a vigorous second-set graft rejection response to a subsequent skin graft. S.  NIMELSTEIN~  Ao  HOTTI~ AND  1~.  ttOLMAN  727 
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FIC. 2.  Cytotoxic antibody of B anti-D serum before and after absorption by test antigen. 
Thus, while SM sensitized for accelerated skin-graft rejection, the mixture did 
not. 
The third column in Table II shows the cytotoxic antibody titers of the ani- 
mals  13 days after grafting. All groups of animals had comparable antibody 
titers except those animals which had received the mixture. This group had sig- 
nificantly lower titers. Thus, one injection of the mixture induced humoral toler- 
ance as measured by cytotoxic antibody production in response to a skin graft. 
Additional  experiments  explored  further  the  humoral  response  to  these 
preparations. B mice received six weekly injections approximately of 0.2 mg D 
SM, 3.2 mg B liver, or 3.7 mg mixture.  4 The mice were bled after this 6-wk pre_ 
4 These were the yields from incubation separately of 0.3 nag D  SM, 60 mg wet weight B 
liver, or the mixture of 0.3 mg D SM, and 60 mg wet weight liver. The antigenic amounts in 
these experiments were designed to be the equivalent of approximately 10 mg wet weight of 
spleen per injection, which had been found to provoke good humoral sensitization in this type 
of multiple injection experiment. 
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TABLE  lI 
Responses  qf B Mice Pretreated with One Injection of Test Antigen 4 Days 
before Receiving  D  Skin  Graft 
Mean log cytotoxic 
Group*  Test antigen  used in pretreatment  Median skin graft  antibody  titer 13 days 
survival time  after grafting 
days 
1  None  10  4- 0,7  2.42  ±  0.14 
2  B liver  10  =E 0.4  2.54  4- 0.18 
3  D SM  7  4- 0.1:~  2.71  4- 0.16 
4  D SM-B liver mixture  10  4- 0.6  1.62  4- 0.22:~ 
* Number of animals in each group: 1 =  14, 2  =  15, 3  =  20, and 4  =  16. 
e  <  o.m. 
treatment and then challenged with weekly injections of cells from }go  of a  D 
spleen. Cvtotoxic assay results are shown in Fig. 4. Animals receiving six weekly 
injections of D  SM developed significant antibody titer. However, those mice re- 
ceiving six injections of the mixture did not. As expected, a control group which 
received weekly injections of syngeneic liver developed no antibody. Thus, the S.  NIMELSTEIN,  A.  HOTTI,  AND  H.  HOLMAN  729 
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FIG. 4.  Tolerogenicity  of altered SM for cytotoxic antibody formation, ll animals in the 
group treated with SM. 12 animals in the other two groups. 
SM was immunogenic and the mixture was not. Furthermore, upon subsequent 
challenge by weekly injections of D spleen cells, the mice pretreated with mixture 
developed significantly lower titers than  the controls injected with syngeneic 
liver. Not shown on this graph, unpretreated controls also challenged with D 
spleen  developed titers similar  to those of the controls pretreated  with syn- 
geneic liver. This result represented a greater than 90% decrease in amount of 
antibody formed in mice treated with mixture as compared to controls. 
Fig. 5 shows the hemagglutinating antibody titers of the same mice. Again, D 
SM was immunogenic while the mixture was not, and the mixture was tolero- 
genic compared to controls. 
Thus, as measured by either cytotoxic or hemagglutinating antibody, allo- 
geneic D  SM  was  immunogenie for humoral  antibody production,  while  the 
allogenic SM pretreated with liver was tolerogenic. 
Finally, the tolerance induced by the mixture was shown to be immunologically 
specific.  Groups of B mice were injected weekly either with 4 mg of the mixture 
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FIG. 5. Tolerogenicity of altered SM for hemagglutiuating antibody formation. Same  ani- 
mals as in Fig. 4. 
or with 7 mg of B  liver along. 5 After 6 wk, the animals were bled, and both of the 
above groups were divided randomly into two subgroups--one subgroup to be 
challenged with D  spleen cells and one with A  spleen cells. The design of this ex- 
periment is based in part upon the fact that A  seroantigens are predominantly 
a  combination of those of D  and K. The results from  those animals challenged 
with D  spleen cells are shown in the first column of Table III. The animals in- 
jected with  the mixture and challenged with D  spleen cells were tolerant when 
compared with animals pretreated with B  liver and similarly challenged. 
The results from those mice challenged with A  spleen cells are shown  in the 
remaining columns of Table III. The second column shows that  sera from ani- 
mals treated with mixture reacted well with A  cells, i.e., the titers were not sig- 
nificantly different from those of control sera. However, the third column shows 
r, Amounts recovered from incubation of 0.3 mg D SM plus 60 mg wet weight B liver and 
from 60 mg wet weight B liver alone, respectively. S.  NIMELSTEIN~  A.  HOTTI~  AND  H.  tIOLMAN  731 
TABLE  III 
Serum  Cylotoxic Antibody Mean Log  Titers of B  Mice t)retreated  for  6 wk as Indicaled and 
then  Challenged  with  12  Weekly  Injections  of  Spleen  Cells 
Pretreatment 
Challenged w/D spleen  Challenged w/A spleen 
Assayed  with  Assayed with  Assayed with  Assayed with 
D lymphoeytes  A lymphocytes  D lymphocytes  K lymphocytes 
B  liver  1.65  =k  0.14  1.93  =/:: 0.20  1.29  :t=  0.22  1.25  ±  0.13 
D  SM-B liver  1.03  =t=  0.13"  1.61  i  0.14~c  0.71  =k  0.07§  1.04  ±  0.05:~ 
mixture 
:  Eight  animals in each group, ti-2 seroantigens present on above  lymphocytes which  are 
recognized byBmiceare:A  =  1,3,4,8,  10, 11, 13, 25;D  =  3, 4, 8,10,  13, 31;K  =  1,  3, 
8,  1l, 25, 32. 
* P  <  0.01. 
:~, insignificant difference. 
§ p  <  0.05. 
that these same sera from animals treated with mixture reacted with D cells at a 
level significantly lower than did sera from controls. As shown in the last  col- 
umn, these sera reacted with K  cells at levels similar to control sera. K  antigens 
constitute essentially those A antigenic specificities not present on D ceils. Thus, 
mice treated with mixture and challenged with D  cells were tolerant and  those 
challenged with A  cells showed significant tolerance to D  antigens, but not  to 
the other A  antigens. Hence, the tolerance was specific. 
DISCUSSION 
In previous work on histocompatibility antigens by Mandel et al. (6) and by 
Pahn  and Manson (7), as in  the present work, incubation with liver was found 
to eliminate the ability of spleen to sensitize for accelerated skin graft rejection. 
This was interpreted to indicate that liver destroyed spleen histocompatibility 
antigens. Similarly, Hilgert and Kristofova (8) found that in some systems pre- 
treatment with liver eliminated the ability of spleen to immunize for antibody 
production as well as to sensitize for accelerated skin graft rejection. However 
the induction  of humoral  tolerance was not studied.  Furthermore  other syn- 
geneic tissues had the same effect as liver. These results were attributed to either 
a  destruction of spleen antigens or to a nonspecific inhibitory effect upon im- 
nmnization of the added tissue in the innoculuin. We have now shown that liver 
extract does not destroy the spleen humoral antigenicity nor does it nonspecifi- 
cally inhibit immunogenicity. Instead, it  transforms the spleen membrane H-2 
antigen from an immunogen to a tolerogen. 
Precedent for transformation of an immunogen into a  tolerogen was estab- 
lished in experiments with flagellin by Parish and others (9). A physical altera- 
tion, i.e., cyanogen bromide cleavage, created a  tolerogenic product from im- 
munogenic flagellin. In our experiments liver may be inducing a physical change 
in  the  spleen antigens,  possibly enzymatically, thereby changing  the in vivo 732  CREATION  OF  HISTOCOMPATIBILIT¥ TOLEROGEN 
properties of the SM from humoral immunogenicity to tolerogenicity. For ex- 
ample, a liver enzyme might be destroying or cleaving a part of the SM antigen 
which is necessary for immunization. Support for this possibility derives from 
the fact that during incubation of the D SM and B liver, soluble D antigen is re- 
leased into the supernatant, indicating that at least some physical alteration is 
occurring. Alternatively, liver may be uncovering an adjacent membrane por- 
tion which combines with antigen to produce a tolerogen. It is also possible that 
the tolerance is not a result of an initial liver-spleen interaction but rather is a 
result of separate effects of liver and spleen on the animal occurring only after in- 
jection. However we have found no evidence of tolerance when liver homogenate 
and D SM were injected separately without prior incubation together. 
Another hypothetical alternative explanation to transformation of the anti- 
gen would be a form of "low dose" tolerance. This would postulate destruction 
of most but not all SM by the liver homogenate; the small amount of remaining 
SM would induce a "low dose" tolerance. This is almost certainly not the case. 
First, the mixture absorbs antibody almost as well as SM alone indicating that 
most if not all antigenicity remains. Second, a single dose of mixture is tolero- 
genic in the graft rejection experiments; to our knowledge "low dose" tolerance 
has not been produced by single doses. Third, we have experimented with mul- 
tiple injections of SM in doses varying from 0.01 to 1.0 mg per injection. No evi- 
dence of low dose humoral tolerance was found. 
Solubilization of histocompatibility antigens from cell membranes has been 
achieved by autodigestion, by treatment with KC1 and by digestion with papain 
(10). These procedures leave a residue of varying antigenicity. In preliminary 
experiments we have found the residue from sequential treatment of SM with 
papain and KC1 to be highly immunogenic for antibody to H-2 antigens. Thus, 
despite the fact some solubilization of antigen occurs in each case, the action of 
liver homogenate on SM appears to differ from that of KC1 and papain. 
Whatever the action of the liver, because both the liver and the recipient mice 
were always of the B strain, H-2 antigenicity of the liver is not involved. As yet, 
we cannot identify the active component of the liver homogenate or the altera- 
tion which it causes. Study of this system may allow further delineation of the 
structure of histocompatibility antigens and the differences between their im- 
munogenic and tolerogenic forms. 
Although  not  affecting  cellular  sensitivity,  a  humoral  histocompatibility 
tolerogen might find clinical application in preventing those components of re- 
jection of grafted organs which are caused by humoral antibody, and in prevent- 
ing rejection of free cell grafts, such as platelets and white cells, where humoral 
antibody presumably has a large role in rejection. 
Finally, the alteration of spleen histocompatibility antigen by a constituent 
of liver raises a theoretical point regarding gene expression.  Although all cells 
of an animal contain the same histocompatibility genes, histocompatibility anti- 
gens are represented differently on different organs.  One explanation,  among S.  NIRIELSTEIN~ A.  HOTTI, AND H.  HOLMAN  733 
several,  is  synthesis  of different  gene products in the different  tissues.  An al- 
ternative hypothesis, raised here, is alteration of the already formed gene pro- 
duct by different intracellular enzymes, which are not necessarily controlled by 
the histocompatibility genes. 
SUMMARY 
H-2 antigens on spleen cell membranes absorb antibody to H-2 antigens and 
induce both humoral and cellular responses. Liver cell membrane H-2 antigens 
by contrast also absorb antibody but do not influence cellular response  and are 
tolerogenic for the humoral response. This paper demonstrates that  syngeneic 
liver cells contain a substance which can transform the properties of allogeneic 
spleen cell membranes into those of allogeneic liver cell membranes, i.e.,  trans- 
form a humoral immunogen into a hmnoral tolerogen. The process appears to be 
accompanied by cleavage of an antigen  component from the  spleen  membrane 
and hence to result in a structural change in the H-2 antigen. 
The authors express appreciation for the expert technical assistance of Jeanette Dilley and 
Ruth Owen Sayre. 
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